<h1>Alembic Pharmaceuticals Announces Board Meeting to Review Quarter-End Financial Results</h1>
Alembic Pharmaceuticals Ltd has announced that its Board of Directors will hold a meeting to review the Unaudited Financial Results for the quarter ended June 30, 2026. The board meeting is scheduled for Tuesday, August 4, 2026.
The company detailed the financial schedule along with updates regarding the trading window for its securities. The notice confirmed that the trading window, which had been closed since July 1, 2026, will reopen 48 hours after the declaration of the financial results.
APLLTD Stock Price Movement
Alembic Pharmaceuticals Limited stock settled lower today, shedding 0.04% with shares reaching ₹797.6 after closing trading for the day. The company recorded a volume of 36,166 shares throughout the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.